Evoq Remedies has announced a board meeting on Friday, October 10, 2025, to consider and approve the financial results for the half-year. This meeting was rescheduled from an earlier date due to unavoidable circumstances. The board will also review the limited review report alongside the financial figures. This update is significant for shareholders awaiting the company's latest financial performance and understanding its operational trajectory for the recent period.